Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for SANDOZ ESOMEPRAZOLE

Brand name

SANDOZ ESOMEPRAZOLE

Company Name

SANDOZ CANADA INCORPORATED

Drug Identification Number

02460939

Ingredients & Strength

ESOMEPRAZOLE (40 MG)

ATC Code

A02BC

ATC Descriptor

DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)

Status

MARKETED

Shortage reports
Brand name	Packaging size	Status	Date Created	Date Updated	Reports
SANDOZ ESOMEPRAZOLE	100	Resolved	2019-11-18	2020-08-24	99066
SANDOZ ESOMEPRAZOLE	30	Resolved	2020-03-30	2022-06-24	109943
SANDOZ ESOMEPRAZOLE	100GRT BO CA	Resolved	2020-11-09	2021-01-13	128155
SANDOZ ESOMEPRAZOLE	500GRT	Resolved	2023-12-19	2024-01-03	213807
SANDOZ ESOMEPRAZOLE	100GRT	Resolved	2025-03-03	2025-03-25	251562
SANDOZ ESOMEPRAZOLE	100GRT	Resolved	2025-10-20	2026-01-08	269898
SANDOZ ESOMEPRAZOLE	500GRT	Resolved	2025-10-20	2025-10-27	269901
SANDOZ ESOMEPRAZOLE	30GRT	Actual shortage	2025-11-10	2025-11-17	271367
SANDOZ ESOMEPRAZOLE	500GRT	Actual shortage	2025-11-17	2025-11-18	271994

1

Showing 1 to 9 of 9

Discontinuation reports
Brand name	Packaging size	Status	Date Created	Date Updated	Reports
SANDOZ ESOMEPRAZOLE	30GRT	Discontinued	2022-06-23	2022-06-23	163310

1

Showing 1 to 1 of 1